
Covid-19ã¯ã¯ãã³ã®å¯åå¿ãšããŠãè³åäžãããæäžåæ°ãããã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ããã11,361%å€ãçºçããŠããŸãã
è³åäžã¯ãè³ã«ã€ãªããåèãè³å
ã®åèã䟵ãããç
æ°ã§ããç±³åœã§ã¯ãæ»å ã®ç¬¬5äœãé害åå ã®ç¬¬1äœãšãªã£ãŠããŸããVAERSã®ããŒã¿ã調æ»ãããšãããCovid-19ã¯ã¯ãã³ã®å¯åå¿ãšããŠãæäžåæ°ããããã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã®115åãã®ç¢ºçã§ãè³åäžããçºçããŠããããšãæããã«ãªã£ãããã§ãã
ç±³åœçŸç 管çã»ã³ã¿ãŒïŒCDCïŒãäž»å¬ããVAERSïŒVaccine Adverse Event Reporting SystemïŒã«ã¯ãç±³åœã§æäžããããã¹ãŠã®ã¯ã¯ãã³ã«å¯ŸããŠå ±åãããå¯åå¿ã®å±¥æŽããŒã¿ãåé²ãããŠããŸãã
CDCã®VAERSããŒã¿ããŒã¹ã§ãCovid-19ã¯ã¯ãã³æ³šå°ãç±³åœã§å±éãããŠä»¥æ¥ãå¯åå¿ãšããŠå ±åãããè³åäžã®ä»¶æ°ãæ€çŽ¢ããŠã¿ããšã2020幎12æãã2022幎2æ11æ¥ãŸã§ã®ããã1幎2ã«æéã§ãè³åäžã䌎ãæå®³äºè±¡å ±åãåèš4,532ä»¶ãããããšãããããŸããã
ããããã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã®å¯åå¿ãšããŠè³åäžãçºçããä»¶æ°ãVAERSããŒã¿ããŒã¹ã§åæ§ã«æ€çŽ¢ããŠã¿ããšã2008幎ãã2020幎ãŸã§ã®13幎éã§ãè³åäžãå«ãæå®³äºè±¡ã®å ±åã¯åèš122ä»¶ã«éããªãããšãæããã«ãªããŸããã
ãã®æ°åãé¡é¢éãã«åãåããšãCovid-19泚å°ã¯ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã®37åã®ç¢ºçã§è³åäžãåŒãèµ·ããããšã蚌æããããšèããããšãã§ããŸãããããããããã®ãããªäž»åŒµãããããããã£ãšå€ãã®äººãCovid-19ã®æ³šå°ãåããŠããã®ã ãããããã¯æ®éã®ããšã ããšèšãããã§ããããããããæ®å¿µãªããããããã®äž»åŒµã¯ã©ã¡ããééã£ãŠããã®ã§ãã
次ã®ã°ã©ãã¯ã2008/2009幎ã®ã€ã³ãã«ãšã³ã¶ã·ãŒãºã³ãã2019-2020幎ã®ã€ã³ãã«ãšã³ã¶ã·ãŒãºã³ãŸã§ã13åã®ãã«ã€ã³ãã«ãšã³ã¶ã·ãŒãºã³ã§æäžãããã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã®ç·æ°ã瀺ãããã®ã§ãããã®ããŒã¿ã¯ãããã«ããCDCã®æ
å ±ããæœåºããããã®ã§ãã
以äžã®ã°ã©ãã¯ãç±³åœã«ãããCovid-19ã¯ã¯ãã³ã®æ¥çš®ãã£ã³ããŒã³éå§ä»¥éã2022幎2æ11æ¥ãŸã§ã«æ¥çš®ãããç·æ°ã§ãã
2008/09幎ã®ã€ã³ãã«ãšã³ã¶ã·ãŒãºã³ãã19/20幎ã®ã€ã³ãã«ãšã³ã¶ã·ãŒãºã³ãŸã§ã®éã«ãç±³åœã§ã¯åèš17å2,040äžåãã®ã€ã³ãã«ãšã³ã¶äºé²æ¥çš®ãè¡ãããŸããã
äžæ¹ãCovid-19ã¯ã¯ãã³æ¥çš®ãã£ã³ããŒã³éå§ãã22幎2æ11æ¥ãŸã§ã«ç±³åœã§æ¥çš®ãããCovid-19ã¯ã¯ãã³ã®ç·éã¯557,637,223ïŒ5å5760äžïŒã§ãã£ãã
ãããã£ãŠã2020幎æ«ããç±³åœã§æäžãããCovid-19泚å°ã®3å以äžã®ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã13幎éã«ç±³åœã§æäžãããããšã«ãªããŸãã
以äžã®ã°ã©ãã¯ã22幎2æ11æ¥ãŸã§ã«ç±³åœã§äžçš®ã®è³åäžãçºçããCovid-19ã¯ã¯ãã³ã«å¯ŸããŠVAERSã«å ±åãããæå®³äºè±¡ã®ä»¶æ°ãšã2008幎ãã2020幎ã®éã«ç±³åœã§äžçš®ã®è³åäžãçºçããã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã«å¯ŸããŠVAERSã«å ±åãããæå®³äºè±¡ã®ä»¶æ°ã瀺ããŠããŸãã
çã®æ°åã ãã§ã14ã¶æã®éã«ãè³åäžãåŒãèµ·ãããCovid-19ã¯ã¯ãã³ã«å¯Ÿããæå®³äºè±¡ã®å ±åã¯ã13幎éã«ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã«å¯ŸããŠè¡ãããå ±åã®37åããã£ãããšãåããã
ããããå®éã«æäžåæ°åœããã®è³åäžçºççãèšç®ããŠã¿ããšãCovid-19ã¯ã¯ãã³ã¯èŠãã以äžã«æå®³ã§ããããšããããã
次ã®ã°ã©ãã¯ãç±³åœã§å¯åå¿ãšããŠè¢«ã£ãè³åäžãããã®ã¯ã¯ãã³æäžåæ°ããã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ãšCovid-19ã¯ã¯ãã³ã®äž¡æ¹ã«ã€ããŠç€ºãããã®ã§ããã
2008幎ãã2020幎ã®éã«ãã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã«å¯Ÿããæå®³äºè±¡å ±åã®ãã¡è³åäžã«è³ã£ãå²åã¯ã14,101,639åæ¥çš®ããã1åã«çžåœããŸãã
ããããCovid-19ã¯ã¯ãã³ãžã®æå®³äºè±¡å ±åã®ãã¡è³åäžã«è³ãå²åã¯ã121,340åæ¥çš®ããã1åã«çžåœããŸãã
ã€ãŸããCovid-19泚å°ã¯ãã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ããã115å/11,361%ã被æ¥çš®è ãè³åäžã«ãããå¯èœæ§ãé«ããšããããšã§ãã
ãããã®æ°åã¯ãCovid-19泚å°ãå®å
šã«å®å
šã§ãããšããåœå±ã®çºèšãå®å
šã«åŠå®ãããã®ã§ãããã¡ããã©è±åœæ¿åºã®å
¬åŒããŒã¿ãCovid-19泚å°ã極ããŠæå¹ã§ãããšããåœå±ã®çºèšãåŠå®ãããã®ã§ããã®ãšåãã§ããã







